AVEO Oncology
AVEO
#7106
Rank
โ‚ฌ0.44 B
Marketcap
12,86ย โ‚ฌ
Share price
0.00%
Change (1 day)
144.98%
Change (1 year)

AVEO Oncology (AVEO) - Net assets

Net assets on the balance sheet as of September 2022 : โ‚ฌ24.72 Million

According to AVEO Oncology 's latest financial reports the company has โ‚ฌ24.72 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AVEO Oncology - Net assets on balance sheet (from 2008 to 2022)

Net assets by year

Year Net assets Change
2021-12-31$โ‚ฌ40.5 M41.15%
2020-12-31$โ‚ฌ28.69 M116.52%
2019-12-31$โ‚ฌ13.25 M-155.68%
2018-12-31$-โ‚ฌ23.8 Million-29.95%
2017-12-31$-โ‚ฌ33.98 Million1758.29%
2016-12-31$-โ‚ฌ1.83 Million-111.6%
2015-12-31$โ‚ฌ15.75 M-7.01%
2014-12-31$โ‚ฌ16.94 M-66.54%
2013-12-31$โ‚ฌ50.64 M-43.68%
2012-12-31$โ‚ฌ89.91 M-47.76%
2011-12-31$โ‚ฌ0.17 B219.02%
2010-12-31$โ‚ฌ53.95 M-737.45%
2009-12-31$-โ‚ฌ8.47 Million-90.8%
2008-12-31$-โ‚ฌ92.06 Million36.51%
2007-12-31$-โ‚ฌ67.44 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Biogen
BIIB
โ‚ฌ15.60 B 63,021.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ26.53 B 107,224.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚ฌ0.18 B 668.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ15.94 B 64,382.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ20.44 B 82,586.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.24 B 33,247.20%๐Ÿ‡บ๐Ÿ‡ธ USA